
Aclairo Pharmaceutical Development Group, Inc.
Sterling, VA, United States aclairo.com From their website, Nov 2026
Work here? Claim this listing
About
Aclairo Pharmaceutical Development Group, Inc. provides nonclinical development and clinical pharmacology consulting for pharmaceutical and biotech companies. It supports drug development programs across toxicology, DMPK/TK, pharmacology, regulatory strategy, and scientific writing. The company is based in Sterling, Virginia, USA.
Services
Cell and Gene Therapy Consulting
Provides strategic advice, program support, and regulatory writing for cell and gene therapy modalities including AAV, lentivirus, LNP-delivered nucleic acids, gene editing, and cell therapies.
Clinical Pharmacology Consulting
Supports pharmacokinetic, pharmacodynamic, dose selection, exposure-response, drug interaction, special population, and regulatory submission work for development programs.
Nonclinical DMPK/TK Consulting
Provides ADME, PK/TK, exposure-toxicity, dose justification, IVIVE, human dose projection, and bioanalytical oversight support.
Nonclinical Drug Development Operations
Provides study monitoring, CRO oversight, vendor and laboratory coordination, timeline management, and reporting support for nonclinical studies.
Nonclinical Drug Development Strategy Consulting
Develops nonclinical development strategies, gap analyses, regulatory approaches, and study plans to support progression to clinic or market.
Nonclinical Pharmacology Consulting
Designs nonclinical pharmacology programs to characterize on- and off-target effects, support dose selection, and integrate pharmacology with toxicology.
Scientific and Regulatory Writing
Prepares submission-ready nonclinical and clinical documents, regulatory applications, reports, meeting packages, and position papers.
Toxicology Consulting
Supports toxicology strategy, study design, monitoring, interpretation, and regulatory interactions across general, genetic, reproductive, juvenile, and other toxicology areas.
3 more services
- Nonclinical DMPK and Toxicokinetics Consulting
- Nonclinical Drug Development Strategy
- Nonclinical Pharmacology
Capabilities
- Assays and studies
- Toxicology
- PK/PD
- Cell therapy
- AAV
- Antibodies
- Small molecules
18 more
- LNP
- Lentivirus
- Bioanalysis
- ADME
- PK
- TK
- Safety pharmacology
- Genetic toxicology
- Developmental and reproductive toxicology
- Juvenile toxicology
- Carcinogenicity
- Phototoxicity
- General toxicology
- Dose selection
- Exposure-response
- Drug interaction
- Special population assessment
- Toxicology study monitoring
- Therapeutic areas
- Neurology
- Immunology
- Oncology
- Urology
- Anti-infectives
- Genetic disorders
4 more
- Cardiovascular
- Metabolic disorders
- Women’s health
- Rare diseases
Modalities and species
- Modalities
- Small molecule
- Antibody
- Bispecific
- ADC
- Peptide
- Oligonucleotide
4 more
- Viral vector
- Cell therapy
- Gene editing
- LNP / formulation
- Species and models
- In vitro
- In silico
- Animals
- Toxicology species
- Immune cells
Industries served
- Pharmaceutical
- Biotech
Details
- Type
- CRO
- Founded
- 2004
- Address
- 45600 Terminal Drive Sterling, VA 20166
- Serves
- United States, European Union, Australia, New Zealand, United Kingdom, China, Japan
- Phone
- (703)471-7060